Stock Alert: Teladoc Health Down 7%

By RTTNews Staff Writer ✉ | Published: 12/16/2020 10:00 AM ET

Shares of Teladoc Health, Inc. (TDOC), a New York-based virtual healthcare services provider, are tumbling almost 7 percent or $13.59 in Wednesday's morning trade at $182.52 despite no company-centric news.

U.S. stocks are mostly lower on Tuesday following the release of disappointing retail sales data. A report from the Commerce Department showed retail sales slumped by much more than expected in the month of November. Trading activity was subdued ahead of the announcement of the Federal Reserve's latest monetary policy decision this afternoon.

Teladoc Health has traded in a range of $79.80 to $253.00 in the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

New Drugs Approved In November

New Drugs Approved In November

PDUFA 2020 Multiple Sclerosis Cystic Fibrosis Edema PAH Sleep wake disorder hereditary angioedema attacks

Biotech Stocks Facing FDA Decision In December 2020

Biotech Stocks Facing FDA Decision In November 2020 COVID19 FDA

Biotech Stocks Facing FDA Decision In November 2020

Editors Pick

United Airlines To Support CDC's Efforts To Curb Covid-19 Spread

United Airlines said it will work on a contact tracing program to support the Centers for Disease Control and Prevention or CDC's efforts to lessen the spread of COVID-19 in the U.S. and around the world. United will collect detailed customer contact information for all international and domestic flights.

Facebook Removes Fake Networks From France And Russia

Facebook has taken down some fake accounts, pages and groups, including a few accounts from Instagram, for violating its policy against "coordinated inauthentic behavior" on behalf of a foreign or government entity. The social media giant said these were part of three separate networks that originated in France and Russia and targeted countries in North Africa and the Middle East.

Honda Recalls Over 1.4 Mln Vehicles For Safety Issues

Honda Motor Co., Ltd. is recalling around 1.4 million vehicles in the United States for issues related to software trouble and faulty drive shafts, reports said. Worldwide, the Japanese automaker's recall includes 1.79 million vehicles. The vehicles are called back in four separate campaigns. Majority of the cars recalled are Honda Accord sedans, which were manufactured between 2018 and 2020.